Charles Schoch
Director of Finance/CFO at CANDEL THERAPEUTICS, INC.
Net worth: 370 694 $ as of 2024-05-30
Network origin in Charles Schoch first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Biotechnology | 16 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Charles Schoch via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
SIGA TECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
CHIMERIX, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
SANOFI | Biotechnology | Chief Tech/Sci/R&D Officer | |
PatientsLikeMe LLC
PatientsLikeMe LLC Internet Software/ServicesTechnology Services PatientsLikeMe LLC operates online health communities for patients. The firm offers data and information on patients, treatments, symptoms and research. The company was founded by Benjamin Heywood, James Heywood and Jeff Cole in 2004 and is headquartered in Cambridge, MA. | Internet Software/Services | Director/Board Member | |
Presage Biosciences, Inc.
Presage Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Presage Biosciences, Inc. engages in development of novel drugs for treatment of cancers. It offers CIVO arrayed microinjection platform that allows for simultaneous assessment of multiple drugs or drug combinations directly in a single solid tumor while still in a patient’s body to assess efficacy, resistance, and drug synergies in the tumor’s native microenvironment. The company was founded by James M. Olson and Thane Kreiner in 2008 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Chief Executive Officer | |
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree | |
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
California State University-Bakersfield | College/University | Undergraduate Degree | |
Yale University | College/University | Graduate Degree Undergraduate Degree | |
The Pennsylvania State University | College/University | Undergraduate Degree | |
University of California, Davis | College/University | Doctorate Degree | |
University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree | |
University of Birmingham | College/University | Corporate Officer/Principal | |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal | |
Sapienza University of Rome | College/University | Doctorate Degree | |
The Foundation Fighting Blindness, Inc.
The Foundation Fighting Blindness, Inc. Miscellaneous Commercial ServicesCommercial Services The Foundation Fighting Blindness, Inc. provides preventions, treatments and cures for people affected by retinitis pigmentosa, macular degeneration and usher syndrome. The firm also provides provide information on retinal degenerative diseases to all who request it, in order to increase knowledge and awareness of these diseases. It has locations in Columbia, Denver, Libertyville, New York, Plano, Raleigh and Santa Monica. The company was founded on September 16, 1971 and is headquartered in Columbia, MD. | Miscellaneous Commercial Services | Director/Board Member | |
Foundation Fighting Blindness Clinical Research Institute
Foundation Fighting Blindness Clinical Research Institute Financial ConglomeratesFinance Foundation Fighting Blindness Clinical Research Institute provides investment services. The company is headquartered in Columbia, MD. | Financial Conglomerates | Director/Board Member | |
OPKO HEALTH, INC. | Medical/Nursing Services | Director/Board Member | |
Keystone Symposia
Keystone Symposia Miscellaneous Commercial ServicesCommercial Services Keystone Symposia operates as a catalyst for the advancement of biomedical and life sciences by connecting scientists within and across disciplines at conferences and workshops. The company was founded by C. Fred Fox in 1972 and is headquartered in Silverthorne, CO. | Miscellaneous Commercial Services | Chairman | |
University of Virginia Community Credit Union
University of Virginia Community Credit Union Savings BanksFinance University of Virginia Community Credit Union operates as a state chartered credit union. The private company is based in Charlottesville, VA and has subsidiaries in the United States. | Savings Banks | Corporate Officer/Principal | |
Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. Pharmaceuticals: MajorHealth Technology Nemucore Medical Innovations, Inc. is a clinical development company. It specializes in the development and commercialization of molecularly targeted therapeutics for the treatment of multi-drug resistant cancers with an emphasis on women's oncology. The company was founded by Timothy P. Coleman, Yuri Lvov, Vladimir Torchilin and Mansoor Amiji in 2008 and is headquartered in Wellesley, MA. | Pharmaceuticals: Major | Director/Board Member | |
PBM Capital Group LLC
PBM Capital Group LLC Investment ManagersFinance PBM Capital Group LLC (PBM Capital Group) is a private equity and venture capital firm founded in 2010 by Paul B. Manning. The firm is headquartered in Charlottesville, Virginia. | Investment Managers | Chief Executive Officer Corporate Officer/Principal | |
PBM Pharmaceuticals, Inc.
PBM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology PBM Pharmaceuticals, Inc. manufactures pharmaceutical products. The private company is based in Charlottesville, VA. | Pharmaceuticals: Major | Director/Board Member | |
Universidad Del Valle De Guatemala | College/University | Doctorate Degree | |
ArcherDX LLC
ArcherDX LLC Packaged SoftwareTechnology Services ArcherDX LLC is a genomic analysis company, which develops software solutions for investigating cancer treatment. Its products include VariantPlex, FusionPlex, LiquidPlex, reveal ctDNA, Immunoverse, custom assays, and archer analysis. The company was founded by Jason W. Myers, A. John Iafrate, and Long Phi Le on January 1, 2013 and is headquartered in Boulder, CO. | Packaged Software | Director/Board Member | |
Harvard College | College/University | Undergraduate Degree | |
Tolerion, Inc.
Tolerion, Inc. Pharmaceuticals: MajorHealth Technology Tolerion, Inc. operates as a clinical-stage biopharmaceutical firm. It develops and commercializes therapeutics. The firm provides TOL-3034 and TOL-3052 to treat myasthenia gravis and neuromyelitis optica. The company was founded by Lawrence J. Steinman and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
Xalud Therapeutics, Inc.
Xalud Therapeutics, Inc. BiotechnologyHealth Technology Xalud Therapeutics, Inc. develops novel therapies with several promising therapeutic programs for inflammatory. The firm offers XT-101, a single dosage injection that stops disease progression, eliminates neuropathic pain, and reverses paralysis. It also researches on the applicability of XT-101 for multiple sclerosis and amyotrophic lateral sclerosis. The company was founded by John Forsayeth and Linda Watkins and is headquartered in San Francisco, CA. | Biotechnology | Chairman Chief Executive Officer | |
VERRICA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Pbm Capital Investments LLC | Chief Executive Officer | ||
UVA Health Foundation
UVA Health Foundation Internet Software/ServicesTechnology Services Part of University of Virginia, UVA Health Foundation operates a healthcare platform. The company is based in Charlottesville, VA. | Internet Software/Services | Director/Board Member | |
DOVA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman | |
Pfizer Essential Health
Pfizer Essential Health Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Essential Health is an American company that manufactures pharmaceutical products. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Sitryx Therapeutics Ltd.
Sitryx Therapeutics Ltd. Medical SpecialtiesHealth Technology Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom. | Medical Specialties | Founder | |
OMEGA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Citryll BV
Citryll BV Miscellaneous Commercial ServicesCommercial Services Citryll BV is a private pharmaceutical company located in Oss, the Netherlands, at the Pivot Park. Citryll is dedicated to developing and commercializing therapeutics that target netosis and NETs, with a focus on immune-mediated inflammatory diseases. The Dutch company's lead antibody, Cit-013, has a unique dual mode of action and proprietary NET biomarker assays, making it a promising drug for rheumatoid arthritis and hidradenitis suppurativa. The initial clinical trials with Cit-013 are expected to provide the foundation for a new treatment paradigm for immune-mediated inflammatory diseases. The company was founded in 2015 by Helmuth van Es, Renato Chirivi, and the late Jos Raats of ModiQuest. | Miscellaneous Commercial Services | Chairman | |
TAYSHA GENE THERAPIES, INC. | Biotechnology | Director/Board Member | |
ALX ONCOLOGY HOLDINGS INC. | Biotechnology | Corporate Officer/Principal | |
RareGen LLC
RareGen LLC Miscellaneous Commercial ServicesCommercial Services RareGen LLC provides strategy, investment, and commercialization for rare disease pharmaceutical products. The company is headquartered in Durham, NC. | Miscellaneous Commercial Services | Director/Board Member | |
LIQUIDIA CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
Institute of Translational Medicine | Corporate Officer/Principal |
Statistics
International
United States | 40 |
United Kingdom | 5 |
France | 2 |
Switzerland | 2 |
Italy | 2 |
Sectoral
Health Technology | 22 |
Consumer Services | 12 |
Commercial Services | 6 |
Finance | 5 |
Technology Services | 4 |
Operational
Director/Board Member | 70 |
Corporate Officer/Principal | 32 |
President | 24 |
Independent Dir/Board Member | 23 |
Chief Executive Officer | 21 |
Most connected contacts
Insiders | |
---|---|
Edward Benz | 29 |
Joseph Papa | 28 |
Paul Manning | 26 |
Susan Stewart | 15 |
Paul-Peter Tak | 15 |
Diem Nguyen | 11 |
Gary Nabel | 9 |
Renee Gaeta | 9 |
William Nichols | 6 |
Estuardo Aguilar-Cordova | 6 |
Francesca Barone | 6 |
Seshu Tyagarajan | 5 |
Nathan Caffo | 4 |
Ileen B. Winick | 4 |
Christopher Martell | 3 |
- Stock Market
- Insiders
- Charles Schoch
- Company connections